Varian Medical Systems and Elekta Settle Patent Litigation

Email

Print This Page

Comment

bookmark

Font : A-A+

PALO ALTO, Calif., April 3, 2017 /PRNewswire/ -- Varian Medical Systems (NYSE: VAR) today announced that it has reached

a confidential settlement agreement with Elekta (EKTA-B) to end ongoing patent litigation involving technology used for radiation oncology and the treatment of cancer. Varian and Elekta resolved the multi-year disputes in the

United States, Germany, and the United Kingdom, including the suit brought by Elekta AB and William Beaumont Hospital, with no payments exchanged by the plaintiffs and defendants and no future financial obligations. The two companies have been in litigation since 2015.

About Varian Medical SystemsVarian Medical Systems focuses energy on saving lives and is the world's leading manufacturer of medical devices and software for treating and managing cancer. Headquartered in Palo Alto, California, Varian employs approximately 6,400 people at sites around the world. For more information, visit http://www.varian.com and follow @VarianMedSys on Twitter.

Press Contact Spencer SiasVarian Medical Systems+1 (650) 424-5782 spencer.sias@varian.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/varian-medical-systems-and-elekta-settle-patent-litigation-300433725.html

SOURCE Varian Medical Systems

Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Find a Doctor

Latest Press Releases

Atlanta Plastic Surgeon Announces Donation for Local Poverty-Based Charity Bruker Introduces Contour LS-K 3D Optical Profiler Connect Biopharmaceuticals Advances CBP-201, a Novel Monoclonal Antibody Against IL-4Ra, Into Clinical Development New member, NJ Wazaney, joins prominent clinicians and business leaders on ABI's advisory boards Astellas Submits New Drug Applications for Approval of Gilteritinib for the Treatment of FLT3mut+ Relapsed or Refractory Acute Myeloid Leukemia

Press Release Category

Hindus welcome Australia's City of Gosnells for Promoting Yoga to Manage Stress Mundipharma Partners with Caris Life Sciences(R) to Launch New Cancer Tumour Profiling Service in Mexico Oncology Company Hercules Pharmaceuticals to Present AhR Inhibitor Efficacy Results at Upcoming AACR Meeting on Monday April 16 DNAe to Present New Data and Preview its Blood-to-Result Test for Bloodstream Infection at ECCMID 2018 Probi Enters the bone Health Area - A New Area for Probiotics

More General News

Press Release Archive

Date:
Category:
Keyword:

What's New on Medindia

Are Steroids Bad For You?

Are Steroids Bad For You?

Steroids are miracle drugs but have to be used with caution. Some steroids are illegal to use, ...

Abruptio Placenta

Abruptio Placenta

Abruptio placenta is a serious but rare complication of pregnancy where a separation of placenta ...

Cyanosis

Cyanosis

Cyanosis is the bluish or purplish discoloration of the skin and mucus membranes due to lack of ...

View All

RapidSSL

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.
Full Disclaimer

Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2018

This site complies with the HONcode standard for trustworthy health information:
verify here.